Decisions on regulatory approval from EMA, UK, and Switzerland for obicetrapib and obicetrapib/ezetimibe fixed-dose combination expected in 2H26, and based on the outcomes, with potential launches by ...

The biology behind muscle pain: calcium chaos, microscopic damage, and the overlooked mechanism that explains how statins can ...

New research suggests that pairing a moderate-intensity statin with ezetimibe can match the cardiovascular benefits of high-intensity statins while reducing the likelihood of developing type 2 ...

The NPPA has capped retail prices for 42 new drugs, covering diabetes, hypertension, and women's health, to keep chronic ...

Cholesterol is a waxy and fat-like substance that the body produces to build cells, produce hormones and digestion, among other functions. It is usually made by the liver, however, you also get it ...

Thousands of lives could be saved by changing the rules around prescribing statins, according to research. The largest analysis to examine the best way to lower levels of "bad" cholesterol in patients ...

The alternative text for this image may have been generated using AI. Medicine has a long tradition of pragmatic empiricism, in which one does what works, regardless of understanding why it works. In ...

The U.S. Food and Drug Administration (FDA) issued a nationwide recall of thousands of bottles of blood-pressure medication last week after discovering cross-contamination with another drug. Federal ...

“As bempedoic acid and ezetimibe are already approved as a single-dose therapy, the development of an oral triple combination with different doses of a statin, will make it easier for physicians to ...

What to do: If your bottle of ezetimibe 10 mg tablets contains any perindopril 4 mg tablets, or if you are unsure, return it to your pharmacy immediately. If you are unable to return your tablets to ...

Please provide your email address to receive an email when new articles are posted on . Obicetrapib plus ezetimibe lowered LDL nearly 50% vs. placebo in patients with high atherosclerotic risk.

A strategy that combines high-intensity statin therapy with ezetimibe early after myocardial infarction results in a lower risk of recurrent events when contrasted with approaches that start ...